Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Upregulated CD8+ MAIT cell differentiation and KLRD1 gene expression after inactivated SARS-CoV-2 vaccination identified by single-cell sequencing. | Front Immunol | 2023 | 37654490 | PubTator, text mining | PubMed |
| Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis. | Oncogene | 2023 | 37653115 | PubTator, text mining | PubMed |
| Aligning the Cord Blood-Bone Marrow Differences and the Post-transplantation Clinical Manifestations by Single-Cell RNA-Seq. | Cell Transplant | 2023 | 37650431 | PubTator, text mining | PubMed |
| Editorial: Advances in the treatment of primary central nervous system lymphoma. | Front Oncol | 2023 | 37645425 | PubTator, text mining | PubMed |
| MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B-cell lymphoma patients. | Cancer Med | 2023 | 37641492 | PubTator, text mining | PubMed |
| Exploration of the antibody-drug conjugate clinical landscape. | MAbs | 2023 | 37639687 | PubTator, text mining | PubMed |
| Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia. | Int J Hematol Oncol Stem Cell Res | 2023 | 37638287 | PubTator, text mining | PubMed |
| Identification of T-cell exhaustion-related gene signature for predicting prognosis in glioblastoma multiforme. | J Cell Mol Med | 2023 | 37635346 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates: Ushering in a New Era of Cancer Therapy. | Pharmaceutics | 2023 | 37631232 | PubTator, text mining | PubMed |
| Genetic Profiling of Cell-Free DNA in Liquid Biopsies: A Complementary Tool for the Diagnosis of B-Cell Lymphomas and the Surveillance of Measurable Residual Disease. | Cancers (Basel) | 2023 | 37627050 | PubTator, text mining | PubMed |
| Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody-drug conjugates, CAR T-cells, and novel agents. | J Hematol Oncol | 2023 | 37626420 | PubTator, text mining | PubMed |
| Contemporary Biomarkers for Renal Transplantation: A Narrative Overview. | J Pers Med | 2023 | 37623466 | PubTator, text mining | PubMed |
| Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas. | Blood | 2023 | 37623434 | PubTator, text mining | PubMed |
| Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma. | Front Immunol | 2023 | 37622116 | PubTator, text mining | PubMed |
| Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles. | Front Neurol | 2023 | 37614975 | PubTator, text mining | PubMed |
| How I Manage Chronic Lymphocytic Leukemia. | Hematol Rep | 2023 | 37606492 | PubTator, text mining | PubMed |
| Comprehensive cell surface protein profiling of human mesenchymal stromal cells from peritoneal dialysis effluent and comparison with those from human bone marrow and adipose tissue. | Hum Cell | 2023 | 37603218 | PubTator, text mining | PubMed |
| A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov. | Discov Oncol | 2023 | 37603124 | PubTator, text mining | PubMed |
| Machine learning models-based on integration of next-generation sequencing testing and tumor cell sizes improve subtype classification of mature B-cell neoplasms. | Front Oncol | 2023 | 37601650 | PubTator, text mining | PubMed |
| Activated PI3Kδ syndrome - reviewing challenges in diagnosis and treatment. | Front Immunol | 2023 | 37600808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=26